Intrinsic Value of S&P & Nasdaq Contact Us

Arvinas, Inc. ARVN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
61/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$11.80
+7.3%

Arvinas, Inc. (ARVN) — Analyst outlook / Analyst consensus target is. Based on 26 analyst ratings, the consensus is bullish — 20 Buy, 5 Hold, 1 Sell.

The consensus price target is $11.80 (low: $6.00, high: $18.00), representing an upside of 7.3% from the current price $11.00.

Analysts estimate Earnings Per Share (EPS) of $-3.15 and revenue of $0.27B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-2.77 vs est $-3.15 (beat +12%). 2025: actual $-1.28 vs est $-0.71 (missed -79.8%). Analyst accuracy: 71%.

ARVN Stock — 12-Month Price Forecast

$11.80
▲ +7.27% Upside
Average Price Target
Based on 26 Wall Street analysts offering 12-month price targets for Arvinas, Inc., the average price target is $11.80, with a high forecast of $18.00, and a low forecast of $6.00.
The average price target represents a +7.27% change from the last price of $11.00.
Highest Price Target
$18.00
Average Price Target
$11.80
Lowest Price Target
$6.00

ARVN Analyst Ratings

Buy
26
Ratings
20 Buy
5 Hold
1 Sell
Based on 26 analysts giving stock ratings to Arvinas, Inc. in the past 3 months
Rating breakdown
Buy
20 77%
Hold
5 19%
Sell
1 4%
77%
Buy
20 analysts
19%
Hold
5 analysts
4%
Sell
1 analysts

EPS Estimates — ARVN

71%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024 Actual –$2.77 vs Est –$3.15 ▲ 13.6% off
2025 Actual –$1.28 vs Est –$0.71 ▼ 44.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Revenue Estimates — ARVN

95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.263B vs Est $0.265B ▼ 0.5% off
2025 Actual $0.263B vs Est $0.289B ▼ 10.2% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message